# Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II

> **NCT02352259** · PHASE2 · COMPLETED · sponsor: **Institute of Oncology Ljubljana** · enrollment: 23 (actual)

## Conditions studied

- Liver Metastases

## Interventions

- **PROCEDURE:** Electrochemotherapy
- **DEVICE:** Cliniporator Vitae®
- **DRUG:** Bleomycin PHC 15 e. (United States Pharmacopeia - USP)

## Key facts

- **NCT ID:** NCT02352259
- **Lead sponsor:** Institute of Oncology Ljubljana
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2018-10
- **Final completion:** 2018-10
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2021-03-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02352259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02352259, "Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02352259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*